
Comparability Study Considerations in the Development and Approval of AMTAGVI (lifileucel)

Speaker Presentation Natarajan Arvind, Iovance Biotherapeutics, 2024
Comparability Study Considerations in the Development and Approval of AMTAGVI (lifileucel)
Comparability Study Considerations in the Development and Approval of AMTAGVI (lifileucel)